AP
Apimeds Pharmaceuticals US, Inc (APUS)
AMEX·Healthcare·Drug Manufacturers - Specialty & Generic
$1.88
+7.43%
Mkt Cap $16.35M
No analyst coverage available
We don't have analyst ratings or price target data for Apimeds Pharmaceuticals US, Inc yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.